Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Document Type

Journal Article

Publication Date

6-2015

Journal

New England Journal of Medicine

Inclusive Pages

Cardiovascular Diseases--complications; Diabetes Mellitus, Type 2--drug therapy; Hypoglycemic Agents--adverse effects; Pyrazines--adverse effects; Triazoles--adverse effects

Peer Reviewed

1

Link to Full Text

Share

COinS